ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
City of Hope at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
City of Hope takes part in 15 sessions at ESMO 2026 in Madrid, and exhibits at Booth 8038. Its work spans cancer treatment, immunotherapy and patient care across several tumour types. It examines personalized cell therapy for recurrent ovarian cancer and ways to manage side effects of immunotherapy.
| Organization | ESMO 2026 Attendance |
|---|---|
City of Hope Duarte, CA | |
Independent cancer research and treatment organization based in Duarte, California, with an NCI-designated comprehensive cancer centre and sites across the US. | Booth Exhibiting at Booth 8038 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 15:15–16:00 Genomic and phenotypic characterization of GPR65, HPK1, ENPP3 and CD70, novel targets of early phase therapeutics for metastatic renal cell carcinoma (mRCC) Genitourinary cancersBiomarkers & precision oncology Poster Fri Oct 23 15:15–16:00 Poster Fri Oct 23 15:15–16:00 Abstract Sat Oct 24 08:30–08:40 Satellite Sat Oct 24 12:00–13:30 Satellite Sat Oct 24 12:00–12:10 Opening: Why Subcutaneous Immunotherapy Now? A Nurse Led Lens Nursing & supportive care Poster Sat Oct 24 12:00–12:45 Satellite Sat Oct 24 12:50–13:25 Nurse Panel session: How best to implement SC IO patient services in hospital and community settings Nursing & supportive care Satellite Sat Oct 24 13:25–13:30 Conclusion remarks Nursing & supportive care Satellite Sat Oct 24 18:43–19:23 Navigating the RCC treatment journey Genitourinary cancersSarcoma, CNS, head & neck and rare cancers Abstract Sun Oct 25 09:22–09:32 Talk Sun Oct 25 10:30–11:15 Poster Sun Oct 25 12:00–12:45 Poster Sun Oct 25 12:00–12:45 PARP inhibitors and platinum chemotherapy improve survival in pancreatic adenocarcinoma independent of HRD status Gastrointestinal cancersBiomarkers & precision oncology Poster Sun Oct 25 12:00–12:45 Predictive response factors to CTLA4/PD-1 combinations in microsatellite stable (MSS) metastatic colorectal cancer (mCRC) Gastrointestinal cancersBiomarkers & precision oncology Talk Sun Oct 25 15:00–15:15 Talk Sun Oct 25 15:55–16:00 Poster Mon Oct 26 12:00–12:45 Talk Mon Oct 26 16:05–16:10 |
Find decision makers at City of Hope
Tell us what you sell and we’ll find the people at City of Hope most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction